Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and Safety of Treating Stage 2 Systolic Hypertension With Olmesartan and Olmesartan/HCTZ: Results of an Open‐Label Titration Study
Joseph L. Izzo, Joel M. Neutel, T SILFANI, et al.
Journal of Clinical Hypertension (2007) Vol. 9, Iss. 1, pp. 36-44
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Olmesartan Medoxomil
Lesley J. Scott, Paul L. McCormack
Drugs (2008) Vol. 68, Iss. 9, pp. 1239-1272
Closed Access | Times Cited: 102
Azilsartan Medoxomil Plus Chlorthalidone Reduces Blood Pressure More Effectively Than Olmesartan Plus Hydrochlorothiazide in Stage 2 Systolic Hypertension
William C. Cushman, George L. Bakris, William B. White, et al.
Hypertension (2012) Vol. 60, Iss. 2, pp. 310-318
Open Access | Times Cited: 67
Comparison of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Essential Hypertension
David H.G. Smith
Drugs (2008) Vol. 68, Iss. 9, pp. 1207-1225
Closed Access | Times Cited: 72
Using Fixed-Dose Combination Therapies to Achieve Blood Pressure Goals
Steven G. Chrysant
Clinical Drug Investigation (2008) Vol. 28, Iss. 11, pp. 713-734
Closed Access | Times Cited: 68
Efficacy and Safety of Long‐Term Treatment With the Combination of Amlodipine Besylate and Olmesartan Medoxomil in Patients With Hypertension
Steven G. Chrysant, Suzanne Oparil, Michael Melino, et al.
Journal of Clinical Hypertension (2009) Vol. 11, Iss. 9, pp. 475-482
Open Access | Times Cited: 62
Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients
Joel M. Neutel
Current Medical Research and Opinion (2008) Vol. 24, Iss. 8, pp. 2389-2401
Closed Access | Times Cited: 57
The Effects of an Olmesartan Medoxomil–Based Treatment Algorithm on 24‐Hour Blood Pressure Levels in Elderly Patients Aged 65 and Older
Dean J. Kereiakes, Joel Neutel, Kathy A. Stoakes, et al.
Journal of Clinical Hypertension (2009) Vol. 11, Iss. 8, pp. 411-421
Open Access | Times Cited: 35
Results of an Olmesartan Medoxomil–Based Treatment Regimen in Hypertensive Patients
Suzanne Oparil, Steven G. Chrysant, Dean J. Kereiakes, et al.
Journal of Clinical Hypertension (2008) Vol. 10, Iss. 12, pp. 911-921
Open Access | Times Cited: 26
Aliskiren Alone or in Combination With Hydrochlorothiazide in Patients With the Lower Ranges of Stage 2 Hypertension: The ACQUIRE Randomized Double‐Blind Study
Henry R. Black, Andreas Kribben, Fernando Aguirre Palacios, et al.
Journal of Clinical Hypertension (2010) Vol. 12, Iss. 12, pp. 917-926
Open Access | Times Cited: 21
Efficacy of an Olmesartan Medoxomil–Based Treatment Algorithm in Patients Stratified by Age, Race, or Sex
Suzanne Oparil, Eduardo Pimenta
Journal of Clinical Hypertension (2009) Vol. 12, Iss. 1, pp. 3-13
Open Access | Times Cited: 18
Treating Systolic Hypertension in the Very Elderly With Valsartan-Hydrochlorothiazide vs Either Monotherapy: ValVET Primary Results
Joseph L. Izzo, Howard Weintraub, Daniel Duprez, et al.
Journal of Clinical Hypertension (2011) Vol. 13, Iss. 10, pp. 722-730
Open Access | Times Cited: 16
Dose-Response Characteristics of Olmesartan Medoxomil and Other Angiotensin Receptor Antagonists
David H.G. Smith
American Journal of Cardiovascular Drugs (2007) Vol. 7, Iss. 5, pp. 347-356
Closed Access | Times Cited: 16
The Use of Olmesartan Medoxomil as Monotherapy or in Combination With Other Antihypertensive Agents in Elderly Hypertensive Patients in Japan
Ikuo Saito, Toshio Kushiro, Koji Hirata, et al.
Journal of Clinical Hypertension (2008) Vol. 10, Iss. 4, pp. 272-279
Open Access | Times Cited: 16
Role of Angiotensin II Type 1 Receptor Antagonists in the Treatment of Hypertension in Patients Aged ≥65 Years
Alan H. Gradman
Drugs & Aging (2009) Vol. 26, Iss. 9, pp. 751-767
Closed Access | Times Cited: 15
Titration of HCTZ to 50 mg Daily in Individuals With Stage 2 Systolic Hypertension Pretreated With an Angiotensin Receptor Blocker
Joseph L. Izzo, Joel M. Neutel, T SILFANI, et al.
Journal of Clinical Hypertension (2007) Vol. 9, Iss. 1, pp. 45-48
Open Access | Times Cited: 15
Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension
Vivencio Barrios, Carlos Escobar
Expert Opinion on Pharmacotherapy (2007) Vol. 9, Iss. 1, pp. 129-136
Closed Access | Times Cited: 13
A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension
William C. Cushman, George L. Bakris, William B. White, et al.
Journal of Hypertension (2018) Vol. 36, Iss. 4, pp. 947-956
Open Access | Times Cited: 9
Influence of Age and Race on 24‐Hour Ambulatory Blood Pressure Responses to Valsartan, Hydrochlorothiazide, and Their Combination: Implications for Clinical Practice
Joseph L. Izzo, Yan Jia, Dion Zappe
Journal of Clinical Hypertension (2016) Vol. 19, Iss. 2, pp. 143-150
Open Access | Times Cited: 8
Efficacy and safety of olmesartan medoxomil alone and in combination with hydrochlorothiazide
Henry Punzi
Expert Review of Cardiovascular Therapy (2009) Vol. 7, Iss. 3, pp. 229-239
Closed Access | Times Cited: 9
Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination
Henry Punzi
Integrated Blood Pressure Control (2011), pp. 73-73
Open Access | Times Cited: 8
Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide
Lars Christian Rump, Lorenz Sellin
Expert Opinion on Pharmacotherapy (2010) Vol. 11, Iss. 13, pp. 2231-2242
Closed Access | Times Cited: 8
Efficacy of Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination Therapy in Patients Aged 65 Years and Older with Stage 1 and 2 Hypertension or Isolated Systolic Hypertension
F. Wilford Germino, Joel M. Neutel, Robert Dubiel, et al.
American Journal of Cardiovascular Drugs (2012) Vol. 12, Iss. 5, pp. 325-333
Closed Access | Times Cited: 7
Combination Therapy with Olmesartan Medoxomil and Hydrochlorothiazide
Steven G. Chrysant, Kathleen J. Chavanu, Jianbo Xu
American Journal of Cardiovascular Drugs (2009) Vol. 9, Iss. 4, pp. 241-251
Closed Access | Times Cited: 7
Safety and Tolerability of an Olmesartan Medoxomil-Based Regimen in Patients with Stage 1 Hypertension
Steven G. Chrysant
Clinical Drug Investigation (2010) Vol. 30, Iss. 7, pp. 473-482
Closed Access | Times Cited: 5
Role of olmesartan in combination therapy in blood pressure control and vascular function
Carlos M. Ferrario
Vascular Health and Risk Management (2010), pp. 701-701
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top